HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haifeng Wang Selected Research

vMIP-II

10/2018The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1.
4/2017N-terminal polypeptide derived from vMIP-II exerts its antitumor activity by inhibiting the CXCR4 pathway in human glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haifeng Wang Research Topics

Disease

61Neoplasms (Cancer)
09/2022 - 08/2002
29Urinary Bladder Neoplasms (Bladder Cancer)
02/2022 - 01/2012
15Infections
04/2022 - 08/2013
12Neoplasm Metastasis (Metastasis)
09/2020 - 12/2007
12Lung Neoplasms (Lung Cancer)
01/2020 - 08/2002
10Inflammation (Inflammations)
01/2022 - 02/2008
10Carcinogenesis
08/2021 - 11/2007
10Breast Neoplasms (Breast Cancer)
06/2019 - 01/2014
9Prostatic Neoplasms (Prostate Cancer)
01/2022 - 11/2014
7Body Weight (Weight, Body)
10/2021 - 01/2012
6Carcinoma (Carcinomatosis)
01/2022 - 05/2011
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 08/2002
5Chronic Obstructive Pulmonary Disease (COPD)
12/2019 - 07/2012
4Pneumonia (Pneumonitis)
01/2022 - 12/2012
4Glioma (Gliomas)
01/2019 - 01/2012
3Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 09/2017
3Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 09/2021
3Adenocarcinoma
07/2021 - 01/2013
3Stomach Neoplasms (Stomach Cancer)
11/2020 - 11/2018
3Ischemia
01/2020 - 12/2009
3Type 2 Diabetes Mellitus (MODY)
11/2018 - 07/2017
3Tonsillitis
01/2018 - 06/2013
3Pharyngitis (Sore Throat)
01/2018 - 06/2013
3Diarrhea
06/2015 - 01/2014
2Fibrosis (Cirrhosis)
06/2022 - 03/2021
2Colorectal Neoplasms (Colorectal Cancer)
09/2020 - 11/2010
2Necrosis
03/2020 - 08/2012
2Stroke (Strokes)
01/2020 - 01/2018
2Hypertension (High Blood Pressure)
01/2020 - 09/2017
2Pathologic Constriction (Stenosis)
01/2020 - 01/2014
2Osteoporosis
01/2020 - 05/2010
2Spinal Cord Injuries (Spinal Cord Injury)
07/2019 - 01/2019
2Virus Diseases (Viral Diseases)
03/2019 - 07/2010
2Brain Neoplasms (Brain Tumor)
01/2019 - 01/2012
2Edema (Dropsy)
12/2018 - 11/2015

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
12/2021 - 11/2007
19Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2014
14MicroRNAs (MicroRNA)IBA
09/2020 - 01/2015
11Biological ProductsIBA
08/2021 - 08/2010
9Messenger RNA (mRNA)IBA
12/2021 - 12/2007
8Pharmaceutical PreparationsIBA
01/2022 - 08/2016
7RNA (Ribonucleic Acid)IBA
02/2022 - 01/2013
7Long Noncoding RNAIBA
01/2022 - 11/2014
6Cisplatin (Platino)FDA LinkGeneric
01/2022 - 05/2019
6CytokinesIBA
01/2022 - 01/2016
5Paclitaxel (Taxol)FDA LinkGeneric
06/2019 - 01/2017
5Peptides (Polypeptides)IBA
10/2018 - 04/2017
4Anti-Bacterial Agents (Antibiotics)IBA
04/2022 - 01/2016
4Antiviral Agents (Antivirals)IBA
02/2022 - 01/2019
4Indicators and Reagents (Reagents)IBA
02/2022 - 09/2012
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 07/2017
4AntigensIBA
02/2018 - 09/2015
4DNA (Deoxyribonucleic Acid)IBA
05/2015 - 11/2007
3C-Reactive ProteinIBA
01/2022 - 10/2018
3Phosphotransferases (Kinase)IBA
12/2021 - 07/2020
3InterleukinsIBA
12/2021 - 04/2016
3Protein Kinases (Protein Kinase)IBA
12/2021 - 05/2008
3Therapeutic UsesIBA
05/2020 - 02/2013
3Monoclonal AntibodiesIBA
01/2020 - 12/2012
3LipopolysaccharidesIBA
01/2020 - 09/2017
3InterferonsIBA
03/2019 - 07/2010
3Matrix Metalloproteinases (MMPs)IBA
02/2019 - 08/2016
3SmokeIBA
10/2018 - 11/2007
3TabletsIBA
01/2018 - 06/2013
3niuhuangIBA
01/2018 - 06/2013
3Prostate-Specific Antigen (Semenogelase)IBA
09/2017 - 11/2014
3CarcinogensIBA
01/2016 - 11/2007
3VaccinesIBA
06/2015 - 01/2014
2Circular RNAIBA
09/2022 - 01/2020
2Adenosine Triphosphatases (ATPase)IBA
02/2022 - 02/2017
2Serotonin (5 Hydroxytryptamine)IBA
01/2022 - 07/2020
2Proteoglycans (Proteoglycan)IBA
01/2022 - 09/2020
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 01/2014
2Lipid NanoparticlesIBA
01/2022 - 10/2017
2Phosphates (Orthophosphate)IBA
10/2021 - 11/2019
2Mevalonic Acid (Mevalonate)IBA
03/2021 - 01/2014
2Metformin (Glucophage)FDA LinkGeneric
02/2021 - 11/2018
2MelatoninIBA
01/2021 - 09/2018
2Small Interfering RNA (siRNA)IBA
01/2021 - 06/2019
2AcidsIBA
09/2020 - 08/2013
2Paroxetine (Paxil)FDA LinkGeneric
07/2020 - 06/2012
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2020 - 02/2019
2AntibodiesIBA
11/2019 - 01/2016
2Complement System Proteins (Complement)IBA
06/2019 - 01/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2019 - 01/2019
2MT 12IBA
02/2019 - 01/2012
2vMIP-IIIBA
10/2018 - 04/2017

Therapy/Procedure

24Therapeutics
06/2022 - 07/2007
7Drug Therapy (Chemotherapy)
08/2021 - 07/2014
7Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2019 - 07/2012
5Cystectomy
08/2021 - 09/2012
3Transplantation
01/2022 - 05/2010
3Intraperitoneal Injections
10/2021 - 11/2019
3Radiotherapy
04/2021 - 12/2018
3Adjuvant Chemotherapy
01/2020 - 11/2010
3Catheters
01/2020 - 03/2012
2Ligation
08/2021 - 11/2010
2Length of Stay
12/2019 - 01/2018
2Precision Medicine
06/2019 - 01/2019
2Stents
03/2019 - 11/2015